Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJOncoAlert Journal Club | Risk-reducing surgeries and survival in young BRCA carriers with breast cancer

Eva Blondeaux • 9 May 2025
VJOncoAlert Journal Club
Breast Cancer

In this latest episode of the VJOncoAlert Journal Club, Eva Blondeaux, MD, University of Genova, Genova, Italy, discusses the association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer, as evaluated in an international cohort study. BRCA carriers with previous breast cancer diagnosis at a young age, risk-reducing mastectomy and risk-reducing salpingo-oophorectomy were both associated with a significant improvement in overall survival.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Eva Blondeaux

Evaluating breastfeeding feasibility after breast cancer in BRCA carriers
0:56
Evaluating breastfeeding feasibility after breast cancer in BRCA carriers
Eva Blondeaux • 14 Sep 2024
Is breastfeeding after breast cancer safe and feasible?
0:49
Is breastfeeding after breast cancer safe and feasible?
Eva Blondeaux • 14 Sep 2024
Lifestyle and pregnancy factors impacting breastfeeding in breast cancer survivors
0:44
Lifestyle and pregnancy factors impacting breastfeeding in breast cancer survivors
Eva Blondeaux • 14 Sep 2024
Counseling breast cancer survivors on breastfeeding
0:47
Counseling breast cancer survivors on breastfeeding
Eva Blondeaux • 14 Sep 2024

Related Videos

Stress and depression linked to tumor transcriptional signatures in breast cancer
1:21
Stress and depression linked to tumor transcriptional signatures in breast cancer
Shipra Gandhi • 31 May 2026
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
1:13
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
Shipra Gandhi • 31 May 2026
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
1:34
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
Shipra Gandhi • 1 Jun 2026
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
0:49
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
Shipra Gandhi • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals